This inventor holds 1 USPTO granted patent. Top assignees: Hokkaido University, Kyoto University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 446 
1 out of 873 
Years Active: 2026
Title: Fumihiko Hattanda: Pharmaceutical Innovation for ADPKD.
Introduction
Fumihiko Hattanda is an inventor associated with Sapporo, Japan. His patent work addresses a treatment approach for autosomal dominant polycystic kidney disease (ADPKD).
Latest Patents
Hattanda is associated with 1 patent, titled “Pharmaceutical Composition for Treating Autosomal Dominant Polycystic Kidney Disease.” The invention describes an oral pharmaceutical composition containing tamibarotene for treating or preventing ADPKD. It specifies a daily dose of 1.4–5.5 mg, with 4.0 mg identified as a particular dosage.
Career Highlights
Hattanda’s listed institutional affiliations include Kyoto University and Hokkaido University. His patent work reflects research into a dosage regimen intended for patients with ADPKD.
Collaborations
The listed collaborators include Kenji Osafune and Shinichi Mae.
Conclusion
Fumihiko Hattanda’s patent contribution focuses on the potential use of oral tamibarotene in a defined dosage range for treating or preventing ADPKD.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile